Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Europe and the US together in India's initiative towards accelerating Medical Tourism
Date 19 November 2025

Europe and the US together in India's initiative towards accelerating Medical Tourism

Announcement The Indian government came ahead with the new transformation in the medical tourism landscape by announcing a transitional visa-on-arrival policy for the US and European travellers to m...

Centessa fixed the price of American Depositary Shares (ADSs)
Date 14 November 2025

Centessa fixed the price of American Depositary Shares (ADSs)

Announcement Centessa Pharmaceuticals plc, a leading clinical-level pharmaceutical company, has fixed the pricing value of its underwritten public offering of around 11,627,907 American Depositary S...

INBRAIN and Microsoft entered a tech-fuelled partnership
Date 13 November 2025

INBRAIN and Microsoft entered a tech-fuelled partnership

Announcement INBRAIN Neuroelectronics, a leading brain-computer interface therapeutics (BCI-Tx) company establishing graphene-related neural technologies, has entered a smart partnership with the po...

Hinge shares skyrocket with the support of valuable investors
Date 12 November 2025

Hinge shares skyrocket with the support of valuable investors

Announcement Hinge Health (HNGE), a leading digital health company offering personalised programs to help individuals deal with musculoskeletal (MSK) pain via virtual care, lifestyle support and exe...

Eli and Novo, at the doorstep of White House with its GLP-1 drugs
Date 11 November 2025

Eli and Novo, at the doorstep of White House with its GLP-1 drugs

Announcement Novo Nordisk and Eli Lilly will provide their GLP-1 drugs via President Donald Trump’s direct-to-consumer marketplace for worth $350 per month. The future pills manufactured by in...

RareSight and PolyActiva in a mission to advance treatments for Rare Pediatric Retinal Diseases
Date 10 November 2025

RareSight and PolyActiva in a mission to advance treatments for Rare Pediatric Retinal Diseases

Announcement The alliances have evolved and faced the challenges together to build a healthy tomorrow. The latest partnership has been introduced in the vast healthcare market. The PolyActiva, a clin...

Kardigan's acquisition strategy to build a Heart Health Company with robust data and platform
Date 10 November 2025

Kardigan's acquisition strategy to build a Heart Health Company with robust data and platform

Announcement The Kardigan, the leading heart health company advancing cardiovascular (CV) drug development, has acquired Prolaio, a clinical-fuelled company modernising care and research with real-w...

SimplyTest and Evexia to enter an expansion purpose-built partnership
Date 07 November 2025

SimplyTest and Evexia to enter an expansion purpose-built partnership

Announcement SimplyTest® has signed a partnership agreement with Evexia Diagnostics, a leading provider of diagnostic laboratory services for unified and functional medicine. With this partnersh...

The UPS's acquisition of billions, a new business strategy
Date 06 November 2025

The UPS's acquisition of billions, a new business strategy

Announcement The United Parcel Service (UPS), a leading logistics, supply chain and shipping management company, a known American multinational operating across 200 countries and territories, has ac...

Xcellon Biologics and IntoCell are in an extensive, purpose-built partnership
Date 05 November 2025

Xcellon Biologics and IntoCell are in an extensive, purpose-built partnership

Announcement IntoCell Inc., a leading biotechnology company establishing linker technologies and next-generation payload for antibody-drug conjugates (ADCs) and Xcellon Biologics, a known US contrac...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.